A phase II study on metastatic breast cancer patients treated with weekly vinorelbine with or without trastuzumab according to HER2 expression: changing the natural history of HER2-positive disease-Reference-Cited by-同舟云学术

A phase II study on metastatic breast cancer patients treated with weekly vinorelbine with or without trastuzumab according to HER2 expression: changing the natural history of HER2-positive disease

Published:2006-04 Issue:4 Volume:17 Page:630-636
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Papaldo P.,Fabi A.,Ferretti G.,Mottolese M.,Cianciulli A.M.,Di Cocco B.,Pino M.S.,Carlini P.,Di Cosimo S.,Sacchi I.,Sperduti I.,Nardoni C.,Cognetti F.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/17/4/630/684578/mdj110.pdf

Reference56 articles.

1. The biology of erbB-2/neu/HER-2 and its role in cancer;Hynes;Biochim Biophys Acta,1994

2. ERBB2 oncogene in human breast cancer and its clinical significance;Révillon;Eur J Cancer,1998

3. Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to HIH 3T3 cells;Di Fiore;Cell,1987

4. erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells;Di Fiore;Science,1987

5. Incerased expression of the putative growth factor receptor p185 HER2 causes trasformation and tumorigenesis of HIH 3T3 cells;Hudziak;Proc Natl Acad Sci USA,1987

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigating The Correlation Between Prolonged Survival In Patients With Advanced HER2+ Breast Cancer And The Activity Of Regulatory T Cells.;2024-03-18

2. Macrophage membrane biomimetic drug delivery system: for inflammation targeted therapy;Journal of Drug Targeting;2023-02-08

3. Nab-paclitaxel and atezolizumab for the treatment of PD-L1-positive, metastatic triple-negative breast cancer: review and future directions;Expert Review of Precision Medicine and Drug Development;2020-02-20

4. Trastuzumab‐induced cardiac toxicity: Is serial assessment of left ventricular ejection fraction during treatment necessary?;The Breast Journal;2019-10-31

5. Nanolongan with Multiple On-Demand Conversions for Ferroptosis–Apoptosis Combined Anticancer Therapy;ACS Nano;2019-01-07